Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human PRKACA Antikörper:
anti-Rat (Rattus) PRKACA Antikörper:
anti-Mouse (Murine) PRKACA Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal PRKACA Primary Antibody für ELISA, WB - ABIN562366
Adachi, Kano, Saido, Murata: Visual screening and analysis for kinase-regulated membrane trafficking pathways that are involved in extensive beta-amyloid secretion. in Genes to cells : devoted to molecular & cellular mechanisms 2009
Human Polyclonal PRKACA Primary Antibody für ICC, IF - ABIN408069
Enns, Morton, Mangalindan, McKnight, Schwartz, Kaeberlein, Kennedy, Rabinovitch, Ladiges: Attenuation of age-related metabolic dysfunction in mice with a targeted disruption of the Cbeta subunit of protein kinase A. in The journals of gerontology. Series A, Biological sciences and medical sciences 2009
Data indicate a subpopulation of the CaV1.2 (zeige CACNA1C Antikörper) channel pore-forming subunit (alpha1C) within nanometer proximity of protein kinase A (PKA) at the sarcolemma of murine and human arterial myocytes.
S1928A KI mice failed to induce long-term potentiation in response to prolonged theta-tetanus (PTT-LTP (zeige SCP2 Antikörper)), a form of synaptic plasticity that requires Cav1.2 (zeige CACNA1C Antikörper) and enhancement of its activity by the beta2-adrenergic receptor (zeige ADRB2 Antikörper) (beta2AR (zeige ADRB2 Antikörper))-cAMP-PKA cascade.
Data show that laminin alpha2beta1gamma1 (Lm211) can inhibit neuregulin 1 (zeige NRG1 Antikörper) type III (Nrg1III) by limiting protein kinase A (PKA) activation, which is required to initiate myelination.
study identifies a new role of Dual-AKAP1 (zeige AKAP1 Antikörper) in regulating mitochondrial trafficking through Miro-2 (zeige RHOT2 Antikörper), and supports a model in which PINK1 (zeige PINK1 Antikörper) and mitochondrial PKA participate in a similar neuroprotective signaling pathway to maintain dendrite connectivity
Data suggest that enzyme activation by cAMP involves highly stable conformation of Prkar1a as it binds to Prkaca; glycine residue, G235, appears to function as hinge in B/C helix conserved in Prkar1a; this "Flipback" conformation plays role in cAMP association to A domain of Prkar1a. (Prkar1a = cyclic AMP-dependent protein kinase RIalpha subunit; Prkaca = cyclic AMP-dependent protein kinase catalytic subunit)
cAMP dependent protein kinase A (PKA) is a key intracellular factor mediating SHH (zeige SHH Antikörper) signaling through regulation of GLI3 (zeige GLI3 Antikörper) processing.
this study shows illustrates for the first time the ability of protein kinase A to increase colony-stimulating factor 1 receptor (zeige CSF1R Antikörper) DNA methylation (zeige HELLS Antikörper) resulting in macrophage maturation
these results suggest that the activation of 5-HT1D receptors selectively enhanced IA via the Gbetagamma of the Go-protein, PKA, and the sequential B-Raf (zeige SNRPE Antikörper)-dependent p38 MAPK (zeige MAPK14 Antikörper) signaling cascade.
These data indicate that LPA increases CCN2 (zeige CTGF Antikörper) expression through the activation of PKC (zeige PKC Antikörper) and PKA. Thus, the regulatory functions of the PKC (zeige PKC Antikörper) and PKA pathways are implicated in the LPA-induced increase in CCN2 (zeige CTGF Antikörper) expression
PKA phosphorylates the ATPase inhibitory factor 1 (zeige ATPIF1 Antikörper) and inactivates its capacity to bind and inhibit the mitochondrial H(+)-ATP synthase.
we propose that the PKA-Smurf1 (zeige SMURF1 Antikörper)-PIPKIgamma pathway has an important role in pulmonary tumorigenesis and imposes substantial clinical impact on development of novel diagnostic markers and therapeutic targets for lung cancer treatment.
The mutated PRKACA proteins lost their ability to bind to PRKAR1A (zeige PRKAR1A Antikörper), and thereby lead to constitutive activation of the PKA pathway. Together with previous reports of PRKAR1A (zeige PRKAR1A Antikörper) mutations in syndromic cardiac myxoma, our study demonstrates the importance of the PKA pathway in the tumourigenesis of cardiac myxoma.
differential regulation of PKA and cell stiffness in unconfined versus confined cells is abrogated by dual, but not individual, inhibition of Piezo1 and myosin II.
PRKACA mutations are present in cortisol-producing adenomas and bilateral adrenal macronodular hyperplasia. PRKACA mutation is associated with more severe autonomous cortisol secretion.
Dual co-expression of human fetal Tau with PKA in Escherichia coli results in multisite Tau phosphorylation including also naturally occurring sites which were not previously considered in the context of 14-3-3 (zeige YWHAQ Antikörper) binding. Tau protein co-expressed with PKA displays tight functional interaction with 14-3-3 (zeige YWHAQ Antikörper) isoforms of a different type.
This review will discuss the effects of PKA phosphorylation on wild-type CFTR (zeige CFTR Antikörper), the consequences of cystic fibrosis (zeige S100A8 Antikörper) mutations on PKA phosphorylation, and the development of therapies that target PKA-mediated signaling. [review]
This interaction is promoted by EPAC1 (zeige RAPGEF3 Antikörper) activation, triggering its translocation to the plasma membrane and binding to NHERF1 (zeige SLC9A3R1 Antikörper). Our findings identify a new CFTR (zeige CFTR Antikörper)-interacting protein and demonstrate that cAMP activates CFTR (zeige CFTR Antikörper) through two different but complementary pathways - the well-known PKA-dependent channel gating pathway and a new mechanism regulating endocytosis that involves EPAC1 (zeige RAPGEF3 Antikörper).
The inhibitory effects of BMP4 (zeige BMP4 Antikörper) on PDGF (zeige PDGFA Antikörper)-induced cell proliferation, collagen synthesis, and calpain-2 (zeige CAPN2 Antikörper) activation are impaired in pulmonary artery smooth muscle cells from pulmonary arterial hypertension patient.
description of PRKACA mutations in 2 cases of primary aldosteronism (PA) patients: a novel variant (p.His88Asp) in a case of sudden onset of PA and a mutation (p.Leu206Arg) in context of hypokalemic aggravation of long-term hypertension; these genetic alterations were not found in a subsequent series of 120 aldosterone-producing adenomas and thereby appear to be very rare events
ceramide as a potent physiological modulator of the Na(+)-ATPase (zeige DNAH8 Antikörper), participating in a regulatory network in kidney cells and counteracting the stimulatory effect of PKA via PKCzeta (zeige PRKCZ Antikörper)
we demonstrate that PKA, PKC (zeige FYN Antikörper) and PI3K pathways crosstalk in porcine male germ cells to crucially regulate GSK3A (zeige GSK3a Antikörper) phosphorylation which subsequently controls cell motility.
PKA and MEK (thus, also pERK) are the intracellular mediators downstream of GPR30 that induce the non-genomic suppression of GnRH-induced LH secretion from bovine AP cells by estradiol or G1
Data indicate that mitochondrial cAMP-dependent protein kinase (PKA) activity is regulated by the protease calpain.
structural basis of selectivity for protein kinase A in complex with Rho-kinase (zeige ROCK1 Antikörper) inhibitors by x-ray crystallography
Purification and characterisation of protein kinase catalytic subunit (PKAcat) from bovine lens.
cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is a member of the Ser/Thr protein kinase family and is a catalytic subunit of cAMP-dependent protein kinase. Alternatively spliced transcript variants encoding distinct isoforms have been observed.
, cAMP-dependent protein kinase catalytic subunit alpha
, protein kinase A catalytic subunit
, cAMP-dependent protein kinase catalytic subunit C alpha
, protein kinase A
, protein kinase, cAMP-dependent, catalytic, alpha
, C-alpha subunit
, sperm cAMP-dependent protein kinase catalytic subunit
, protein kinase A alpha
, PKA catalytic subunit alpha